Effect of screening with a pan-TRK immunohistochemistry-based algorithm on NTRK fusion detection rates

被引：0
|
作者：
Garcia-Rivello, Hernan Jorge
Jauk, Federico
Pandolfi, Julieta
Hermida, Paula Gonzalez
Cayol, Federico
Roitman, Pablo
Wernicke, Alejandra
Jaen, Ana Del Valle
Leonardi, Maria Laura
Santino, Juan Pablo
Minatta, Jose Nicolas
Caballero, Gustavo, Sr.
Cortes, Claudia Alejandra Franco
Lupinacci, Lorena
Mazza, Malena
Volonteri, Victoria
de La Iglesia, Paola
机构：
[1] MTIB, Caba, Argentina
[2] Ist oncol Ric IOR, Bellinzona, Switzerland
[3] Hosp Italiano Buenos Aires, Caba, Argentina
[4] Hosp Univ Austral, Pilar, Argentina
[5] Fdn Favaloro, Caba, Argentina
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15135
引用
收藏
页数：1
相关论文
共 46 条
  • [21] Pan-Trk immunohistochemistry reliably identifies ETV6-NTRK3 fusion in secretory carcinoma of the salivary gland
    Diana Bell
    Renata Ferrarotto
    Li Liang
    Ryan P. Goepfert
    Jie Li
    Jing Ning
    Russell Broaddus
    Randal S. Weber
    Adel K. El-Naggar
    Virchows Archiv, 2020, 476 : 295 - 305
  • [22] Spitz Tumors With NTRK1 Fusions TRK-A and pan-TRK Immunohistochemistry as Ancillary Diagnostic Tools
    Uguen, Arnaud
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2019, 43 (10) : 1438 - 1439
  • [23] Pan-TRK IHC Is an Efficient and Reliable Screening Assay for Targetable NTRK Fusions
    Hechtman, Jaclyn F.
    Drilon, Alexander
    Hyman, David M.
    Zehir, Ahmet
    Dogan, Snjezana
    Arcila, Maria E.
    Ladanyi, Marc
    Benayed, Ryma
    Jungbluth, Achim
    MODERN PATHOLOGY, 2017, 30 : 457A - 457A
  • [24] Use of pan-TRK immunohistochemistry for identification of NTRK fusions in mesenchymal neoplasms - real life experience
    Brcic, I.
    Godschachner, T. M.
    Bergovec, M.
    Igrec, J.
    Scheipl, S.
    Kashofer, K.
    Leithner, A.
    Szkandera, J.
    Liegl-Atzwanger, B.
    VIRCHOWS ARCHIV, 2020, 477 : S19 - S19
  • [25] Pan-TRK IHC Is an Efficient and Reliable Screening Assay for Targetable NTRK Fusions
    Hechtman, Jaclyn F.
    Drilon, Alexander
    Hyman, David M.
    Zehir, Ahmet
    Dogan, Snjezana
    Arcila, Maria E.
    Ladanyi, Marc
    Benayed, Ryma
    Jungbluth, Achim
    LABORATORY INVESTIGATION, 2017, 97 : 457A - 457A
  • [26] Screening for NTRK-rearranged Tumors Using Immunohistochemistry: Comparison of 2 Different pan-TRK Clones in Melanoma Samples
    Bourhis, Amelie
    Redoulez, Geoffroy
    Quintin-Roue, Isabelle
    Marcorelles, Pascale
    Uguen, Arnaud
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2020, 28 (03) : 194 - 196
  • [27] Detection of NTRK fusions in glioblastoma: fluorescent in situ hybridisation is more useful than pan-TRK immunohistochemistry as a screening tool prior to RNA sequencing
    Bourhis, Amelie
    Caumont, Charline
    Quintin-Roue, Isabelle
    Magro, Elsa
    Dissaux, Gurvan
    Remoue, Annabelle
    Le Noac'h, Pierre
    Douet-Guilbert, Nathalie
    Seizeur, Romuald
    Tyulyandina, Alexandra
    Schick, Ulrike
    Merlio, Jean-Philippe
    Marcorelles, Pascale
    Cappellen, David
    Uguen, Arnaud
    PATHOLOGY, 2022, 54 (01) : 55 - 62
  • [28] Using pan-TRK and RET Immunohistochemistry for the Detection of Fusion Types of Salivary Gland Secretory Carcinoma
    Su, Yu-Ju
    Lee, Yi-Hsuan
    Jin, Ying-Tai
    Hsieh, Min-Shu
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2022, 30 (04) : 264 - 272
  • [29] Pan-TRK Immunohistochemistry Is Highly Correlated With NTRK3 Gene Rearrangements in Salivary Gland Tumors
    Csanyi-Bastien, Marie
    Lanic, Marie-Delphine
    Beaussire, Ludivine
    Ferric, Sandra
    Francois, Arnaud
    Meseure, Didier
    Jardin, Fabrice
    Wassef, Michel
    Ruminy, Philippe
    Lae, Marick
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2021, 45 (11) : 1487 - 1498
  • [30] Predictive 'biomarker piggybacking': an examination of reflexive pan-cancer screening with pan-TRK immunohistochemistry
    Sholl, Lynette M.
    Zheng, Mei
    Nardi, Valentina
    Hornick, Jason L.
    HISTOPATHOLOGY, 2021, 79 (02) : 260 - 264
12345